Trajan acquires LEAP Technologies
Trajan Scientific and Medical has announced the acquisition of LEAP Technologies, which was formed in 1989 in order to serve the automation needs of chromatography- and mass spectrometry-related analytical laboratories.
LEAP delivers solutions in the fields of research and development, life science, pharmaceutical, polymer, food processing, forensics and academia. Trajan believes the acquisition of LEAP will service the company’s vision to make a positive impact on human wellbeing, improving laboratory workflows to ultimately bring testing of the sample closer to the source while supporting improved efficiencies in the lab.
“We are so pleased to welcome the LEAP team into the Trajan family,” said Trajan CEO Stephen Tomisich. “Trajan has a technology-rich development pipeline of disruptive sampling and sample preparation products speeding towards commercialisation, and LEAP provides the automation capability to allow adoption into laboratory workflows. We think it’s a partnership with huge potential.”
“LEAP’s team is very pleased about becoming part of the Trajan organisation,” said LEAP CEO Sal Iacono. “In particular, the expanded opportunities to generate more disruptive, efficient and streamlined solution … for the life science, environmental and diagnostic markets [are] immensely exciting. We are eagerly looking forward to continuing and further expanding our relationships with superb technology partners … in integrating their outstanding offerings with Trajan’s many disruptive technologies to provide superior innovation to the marketplace.”
“The opportunity for LEAP to join Trajan will be a tremendous step forward to best apply new automation configurations for the fast-evolving analytical chemistry laboratories worldwide,” said LEAP President Werner Martin. “The synergies are multiple and can speed up the positive impact on human wellbeing by improving developments for laboratory automation and workflow.”
WA Govt creates Science and Technology Council
The council will offer independent advice on emerging opportunities and challenges, promoting...
Billion-dollar deal for UQ's molecular clamp vaccine tech
Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...
Director of scandal-ridden Forensic Science Queensland resigns
Dr Linzi Wilson-Wilde resigned from her position one month after being suspended by Queensland...